An update from Peak Bio (PKBO) is now available.
Stephen LaMond has stepped down as the Interim CEO and COO of Peak Bio, Inc., and will transition to a consulting role to aid in handing over to new management. His departure is coupled with a separation agreement that includes a consulting fee and stock options, while Hoyoung Huh will take over CEO duties effective immediately. LaMond’s agreement includes financial compensation and benefits, ensuring a smooth management transition.
For an in-depth examination of PKBO stock, go to TipRanks’ Stock Analysis page.